$ATRA Atara Biotherapeutics, Inc. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Atara Biotherapeutics, Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in Atara Biotherapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Atara Biotherapeutics, Inc. for free.

CIK Number: 0001604464
IRS Number: 460920988
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: ATRA
Company Address: 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO 94080

Atara Biotherapeutics, Inc. operates as a clinical stage biopharmaceutical company which focuses on developing novel therapeutics for serious unmet medical needs, with an initial focus on muscle wasting conditions and oncology. Its product candidates are biologics targeting myostatin and activin, members of the transforming growth factor-beta, protein superfamily, which play roles in the growth and maintenance of muscle and many other body tissues. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA.

Market Capitalization: $434.34M
Prev close: $15.05
Average Daily Volume: 231,402
Days Low: $14.70
Year Low: $12.45
Year High: $25.73

Atara Biotherapeutics, Inc. Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
Ciechanover Isaac E.Chief Executive Officer518,1787,798,579shares bought: 508,630 / shares sold: -540,657 SELLMar 20 20178 days ago
Clark Mitchall G.EVP & Chief R & QA Officer152,7202,298,436shares bought: 78,346 / shares sold: -10,207 STRONG BUYFeb 16 20171 month ago
DOBMEIER ERICDirector7,500112,875shares bought: 5,000 / shares sold: 0 STRONG BUYJan 05 20173 months ago
Fust Matthew KDirector20,696311,475shares bought: 8,410 / shares sold: 0 STRONG BUYFeb 16 20171 month ago
Gallagher Carol GiltnerDirector102,5581,543,498shares bought: 11,463 / shares sold: -3,551 STRONG BUYFeb 16 20171 month ago
Haqq ChristopherEVP, R&D & Chief Scientific Of386,8555,822,168shares bought: 142,817 / shares sold: -51,202 STRONG BUYMar 17 201711 days ago
HEIDEN WILLIAM KDirector2,00030,100shares bought: 2,000 / shares sold: 0 BUYJan 05 20173 months ago
MARCUS JOEL SDirector2,00030,100shares bought: 2,000 / shares sold: 0 BUYJan 05 20173 months ago
MCGRATH JOHNEVP & Chief Financial Officer119,3271,795,871shares bought: 91,508 / shares sold: -62,395 BUYMar 23 20175 days ago
SEIDENBERG BETH CDirector8,689130,769shares bought: 2,000 / shares sold: 0 BUYJan 05 20173 months ago
Sofer GadEVP & Chief Strategy Officer266,5274,011,231shares bought: 190,045 / shares sold: -52,028 STRONG BUYMar 13 201715 days ago
Turner Heather DEVP, General Counsel & Sec.98,3571,480,273shares bought: 49,500 / shares sold: 0 BUYFeb 08 20172 months ago

View all Atara Biotherapeutics, Inc. insiders.

Atara Biotherapeutics, Inc. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 23 2017ATRAAtara Biotherapeut ...MCGRATH JOHNEVP & Chief Financi ...SellS21.086,500137,020112,827119.3 K to 112.8 K (-5.45 %)
Mar 23 2017ATRAAtara Biotherapeut ...MCGRATH JOHNEVP & Chief Financi ...SellS20.277,500152,025119,327126.8 K to 119.3 K (-5.91 %)
Mar 20 2017ATRAAtara Biotherapeut ...Ciechanover Isaac E.Chief Executive Off ...SellS20.0117,600352,176498,178515.8 K to 498.2 K (-3.41 %)
Mar 20 2017ATRAAtara Biotherapeut ...Ciechanover Isaac E.Chief Executive Off ...SellS18.502,40044,400515,778518.2 K to 515.8 K (-0.46 %)
Mar 20 2017ATRAAtara Biotherapeut ...Ciechanover Isaac E.Chief Executive Off ...SellS18.5410,800200,232518,178529 K to 518.2 K (-2.04 %)
Mar 17 2017ATRAAtara Biotherapeut ...Haqq ChristopherEVP, R&D & Chief Sc ...SellS19.606,000117,600386,855392.9 K to 386.9 K (-1.53 %)
Mar 13 2017ATRAAtara Biotherapeut ...Soffer GadEVP & Chief Strateg ...SellS20.002,50050,000266,527269 K to 266.5 K (-0.93 %)
Mar 10 2017ATRAAtara Biotherapeut ...MCGRATH JOHNEVP & Chief Financi ...SellS20.0024,000480,000126,827150.8 K to 126.8 K (-15.91 %)
Feb 22 2017ATRAAtara Biotherapeut ...MCGRATH JOHNEVP & Chief Financi ...SellS15.149,000136,260150,827159.8 K to 150.8 K (-5.63 %)
Feb 16 2017ATRAAtara Biotherapeut ...Gallagher Carol GiltnerDirectorOption ExerciseM0.0081703,814
Feb 16 2017ATRAAtara Biotherapeut ...Gallagher Carol GiltnerDirectorOption ExerciseM0.001,54806,194
Feb 16 2017ATRAAtara Biotherapeut ...Gallagher Carol GiltnerDirectorSellS16.101,18319,046102,192103.4 K to 102.2 K (-1.14 %)
Feb 16 2017ATRAAtara Biotherapeut ...Gallagher Carol GiltnerDirectorBuyM0.008170103,375102.6 K to 103.4 K (+0.80 %)
Feb 16 2017ATRAAtara Biotherapeut ...Gallagher Carol GiltnerDirectorBuyM0.001,5480102,558101 K to 102.6 K (+1.53 %)
Feb 16 2017ATRAAtara Biotherapeut ...MCGRATH JOHNEVP & Chief Financi ...Option ExerciseM0.007,697028,224

View all Atara Biotherapeutics, Inc. insider transactions.